Guy Delespesse

This inventor holds 6 USPTO granted patents. Top assignees: Ciba-Geigy Corporation, Novartis Ag. Active years: 1989-1999.

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 30(Granted Patents)

Company Filing History:

5 out of 6,858

Ciba-Geigy Corporation

Years Active: 1989-1999

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5874228 - Methods and kits for determining the levels of IGE-BF (1999-02-23),

2. 5843676 - Purified immunoglobulin-related factor, novel monoclonal antibodies, (1998-12-01),

3. 5371073 - Polypeptide factors from colostrum (1994-12-06),

4. 5272255 - Polypeptide factors from colostrum (1993-12-21),

5. 4946788 - Purified immunoglobulin-related factor, novel monoclonal antibodies, (1990-08-07),

6. 4866037 - Polypeptide factors from colostrum (1989-09-12),

Title: Guy Delespesse: Innovator in Allergy Diagnosis and Treatment

Introduction

Guy Delespesse is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of immunology, particularly in the diagnosis and treatment of allergic diseases. With a total of 6 patents to his name, Delespesse's work has had a profound impact on medical science.

Latest Patents

Delespesse's latest patents focus on methods and kits for determining the levels of immunoglobulin E binding factors (IgE-BFs). These inventions relate to novel purified human IgE-BFs, including their individual optionally glycosylated proteins and fragments. The patents detail processes for the purification of IgE-BFs and the development of novel monoclonal antibodies that interact with lymphocyte cellular receptors for IgE. These antibodies are crucial for the qualitative and quantitative determination of IgE-BFs and are used in test kits designed for allergy diagnosis. Furthermore, the inventions explore the use of purified IgE-BFs and their derivatives for the prevention and treatment of allergies, highlighting their importance in pharmaceutical preparations.

Career Highlights

Throughout his career, Guy Delespesse has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Ciba-Geigy Corporation and Novartis AG. His experience in these organizations has contributed to his expertise in immunology and the development of innovative solutions for allergy-related health issues.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Guy Delespesse's contributions to the field of immunology through his patents and career experiences have significantly advanced the understanding and treatment of allergic diseases. His work continues to influence the development of effective diagnostic and therapeutic methods.